Call Now

ELISA kit for Homo sapiens (Human) BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3)

C6.1A; BRCC36; C6.1A; CXorf53; Lys-63-specific deubiquitinase BRCC36; BRCA1-A complex subunit BRCC36; BRISC complex subunit BRCC36

Description: BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3)

Organism Species: Homo sapiens (Human)

Sample Type: Tissue homogenates, cell lysates and other biological fluids

Test Method: Double-antibody Sandwich

Assay Length: 3h

Detection Range: 0.156-10ng/mL

Sensitivity: The minimum detectable dose of this kit is typically less than 0.065ng/mL.

Specificity: This assay has high sensitivity and excellent specificity for detection of BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3). No significant cross-reactivity or interference between BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3) and analogues was observed.

Typical Standard Curve:

Typical standard curve for BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3)

Results Demonstration:

Results demonstration for BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3)

Stability: The stability of the kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage conditions. To minimize additional influences on performance, operation procedures and laboratory conditions, especially room temperature, air humidity and incubator temperature, should be strictly controlled. It is also strongly suggested that the entire assay be performed by the same operator from beginning to end.

Storage: Store at 4°C for frequent use. When stored at -20°C in a manual-defrost freezer, the kit can be kept for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Notes: For in vitro laboratory use only. Not for clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Recovery

Matrices listed below may be used to evaluate recovery by spiking a known amount of recombinant BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3) and comparing the measured concentration with the expected concentration.

Recovery data are not displayed here because product-specific validated results have not been supplied for this page. Please refer to the product-specific validation documentation or contact us for further information.

Precision

Intra-assay Precision: Three samples containing low, medium and high levels of BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3) are tested in replicates within one assay.

Inter-assay Precision: Three samples containing low, medium and high levels of BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3) are tested across different assay plates.

CV (%) = (SD / Mean) × 100

Intra-assay: CV < 10%
Inter-assay: CV < 12%

Linearity

The linearity of the kit can be evaluated by testing samples spiked with an appropriate concentration of BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3) and their serial dilutions. Results are expressed as the percentage of the calculated concentration relative to the expected concentration.

Product-specific linearity results should be based on validated experimental data. Please contact us for further information.

Reagents and Materials Provided

Reagents Quantity Reagents Quantity
Pre-coated, ready-to-use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1 × 20 mL
Detection Reagent A 1 × 120 µL Assay Diluent A 1 × 12 mL
Detection Reagent B 1 × 120 µL Assay Diluent B 1 × 12 mL
TMB Substrate 1 × 9 mL Stop Solution 1 × 6 mL
Wash Buffer (30× concentrate) 1 × 20 mL Instruction Manual 1

Assay Procedure Summary

  1. Prepare all reagents, samples and standards.
  2. Add 100 µL of standard or sample to each well. Incubate for 1 hour at 37°C.
  3. Aspirate and add 100 µL of prepared Detection Reagent A. Incubate for 1 hour at 37°C.
  4. Aspirate and wash 3 times.
  5. Add 100 µL of prepared Detection Reagent B. Incubate for 30 minutes at 37°C.
  6. Aspirate and wash 5 times.
  7. Add 90 µL of Substrate Solution. Incubate for 10–20 minutes at 37°C.
  8. Add 50 µL of Stop Solution. Read at 450 nm immediately.

Please follow the product-specific instruction manual for the complete assay procedure.

Test Principle

The test principle applied in this kit is a sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3). Next, avidin conjugated to horseradish peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3), biotin-conjugated antibody and enzyme-conjugated avidin will exhibit a color change. The enzyme-substrate reaction is terminated by the addition of sulfuric acid solution, and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 10 nm. The concentration of BRCA1/BRCA2 Containing Complex Subunit 3 (BRCC3) in the samples is then determined by comparing the O.D. of the samples to the standard curve.